YC-backed ReactWise is applying AI to speed up drug manufacturing | TechCrunch
Briefly

ReactWise, a Cambridge-based startup, leverages AI to revolutionize chemical manufacturing in the pharmaceutical industry. By acting as an 'AI copilot' for chemical process optimization, ReactWise aims to cut down the time and iteration needed to produce drugs for clinical trials by 30 times. CEO Alexander Pomberger likens drug manufacturing to finding the best cooking recipe for high-purity and high-yield outcomes. The company's ultimately goal is to achieve immediate predictions for ideal experiments, which may transform drug development processes significantly in the near future.
Making drugs is really like cooking,' said co-founder and CEO Alexander Pomberger. 'You need to find the best recipe to make a drug with a high purity and a high yield.'
The startup thinks it will be able to deliver 'one shot prediction'... where the AI will be able to 'predict the ideal experiment' almost immediately.
Read at TechCrunch
[
|
]